All lobbying filings

TULIPIFERA STRATEGIES

Lobbying for TREATMENT ADVOCACY CENTER · Advocacy, education, and research related to eliminating barriers to the treatment of SMI.

Filing 2nd Quarter - Amendment

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Aug 5, 2025

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Medicaid IMD Exclusion. The IMD Exclusion, within Sec. 1905(a) of the Social Security Act, generally excludes federal fund participation for treatment provided in an inpatient psychiatric facility.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.